EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Novavax (NASDAQ:NVAX) Trading Down 6.9% - Time to Sell? - Daily Political
How Investors May Respond To Novavax (NVAX) Shareholder Revolt Over Pay And Board Governance
Novavax (NVAX) Faces Shareholder Backlash Despite AGM Resolutions Approval
Novavax Inc Annual Shareholders Meeting Transcript
Novavax (NVAX) Is Up 11.0% After New Pfizer Matrix-M License And Fresh Adjuvant Deals - Has The Bull Case Changed?
Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?
Novavax (NVAX) Stock Revalued After Pivot To Sanofi Deal And Matrix M Licensing Model
Novavax (NASDAQ:NVAX) Given Buy Rating at BTIG Research - Daily Political
Critical Contrast: DNAPrint Genomics (OTCMKTS:DNAG) and Novavax (NASDAQ:NVAX) - Markets Daily
Novavax Pivots To Matrix M Licensing As Sanofi Takes Europe
Is Novavax (NVAX) Trading Near Fair Value As It Pivots Toward Royalties And Licensing?
Novavax (NASDAQ:NVAX) Trading Down 6.2% - Should You Sell? - Daily Political
Novavax to Participate in 2026 Jefferies Global Healthcare Conference
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
